TAK
Takeda Pharmaceutical Co Ltd
17.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.7% | -4.2% | +2.2% | +18.5% | +56.9% | -2.8% | +11.6% | +12.8% | +5.9% | +7.5% | +4.3% | |
| – | +2.8% | +4.4% | -11.2% | +33.0% | +65.2% | -8.8% | +11.3% | +12.4% | +15.1% | +10.4% | +48.0% | |
| – | +1.2% | -7.8% | +8.6% | +12.8% | +53.1% | +0.1% | +11.7% | +13.0% | +1.8% | +6.0% | -18.7% | |
| – | -9.5% | -9.7% | +4.2% | +13.2% | +33.7% | -7.4% | +15.4% | +20.4% | +15.3% | +0.0% | -1.9% | |
| – | +30.3% | -4.9% | +1.5% | +14.2% | +34.4% | -9.2% | +1.2% | +12.5% | +5.7% | +4.8% | -1.9% | |
| – | -17.7% | -10.8% | +1.5% | +23.7% | +64.5% | -19.4% | +18.1% | +14.6% | +14.2% | +1.5% | -29.8% | |
| – | – | +19.1% | +55.1% | -15.2% | -51.0% | +407.2% | -9.5% | +6.4% | -56.4% | +60.0% | +67.3% | |
| – | -2.9% | -27.2% | +37.3% | +50.8% | -97.0% | +8,868.4% | -6.4% | -4.5% | -99.1% | +12,824.1% | +176.1% | |
| – | – | +18.9% | +51.5% | -56.3% | -164.0% | – | -17.4% | +24.0% | -85.9% | +231.7% | +57.6% | |
| – | – | -24.9% | +9.6% | -146.3% | – | – | – | -19.8% | -257.5% | – | +8.0% | |
| – | – | +43.4% | +62.6% | -41.6% | -59.5% | +749.9% | -38.8% | +37.8% | -54.6% | -25.1% | +88.4% | |
| – | +510.7% | -15.1% | +21.2% | +29.0% | +44.7% | +46.4% | +20.3% | +8.5% | -10.9% | +5.8% | +17.3% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.